These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6121453)
1. A new beta 2-adrenoceptor agonist with alpha 1-adrenoceptor blocking properties. Olsson OA; Ahlquist B; Gustafsson B Acta Pharmacol Toxicol (Copenh); 1981 Apr; 48(4):340-8. PubMed ID: 6121453 [TBL] [Abstract][Full Text] [Related]
2. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent. Miyagishi A; Nakahara H; Hara Y Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068 [TBL] [Abstract][Full Text] [Related]
3. The effects in myometrial preparations of D2343, a beta 2-adrenoceptor agonist possessing alpha 1-receptor blocking qualities. Olsson OA; Ahlquist B; Gustafsson B; Persson G Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):391-7. PubMed ID: 6152105 [TBL] [Abstract][Full Text] [Related]
4. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis). Hopkins BJ; Hodgson WC; Sutherland SK Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and adrenergic properties of new duplicated analogs of methoxamine. Perez F; Rosell G; Mauleon D; Carganico G Farmaco; 1991 Oct; 46(10):1155-66. PubMed ID: 1687722 [TBL] [Abstract][Full Text] [Related]
6. The effect of D2343 in transmurally stimulated rabbit isthmus muscle. Olsson OA; Gustafsson B Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):427-30. PubMed ID: 2863921 [TBL] [Abstract][Full Text] [Related]
7. An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity. Kenakin TP J Pharmacol Exp Ther; 1981 Feb; 216(2):210-9. PubMed ID: 6109772 [TBL] [Abstract][Full Text] [Related]
8. The classical competitive antagonism of phentolamine on smooth muscle preparations, investigated by two procedures. Patil PN Auton Autacoid Pharmacol; 2007 Jan; 27(1):71-7. PubMed ID: 17199878 [TBL] [Abstract][Full Text] [Related]
9. The sympathomimetic activity of N-isopropyloctopamine in vitro. Anderson WG J Pharmacol Exp Ther; 1983 Jun; 225(3):553-8. PubMed ID: 6306210 [TBL] [Abstract][Full Text] [Related]
10. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens. Minneman KP; Fox AW; Abel PW Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645 [TBL] [Abstract][Full Text] [Related]
12. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens. Minneman KP; Abel PW Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249 [TBL] [Abstract][Full Text] [Related]
13. [Blocking action of berberine on alpha 2 and alpha 1 adrenoceptors in the rat vas deferens and anococcygeus muscle]. Yao WX; Ling BD; Chen B; Han H; Fang DC; Jiang MX Zhongguo Yao Li Xue Bao; 1986 Nov; 7(6):511-5. PubMed ID: 2886004 [No Abstract] [Full Text] [Related]
14. Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent. Asano M; Uchida W; Shibasaki K; Terai M; Inagaki O; Takenaka T; Matsumoto Y; Fujikura T J Pharmacol Exp Ther; 1990 Jul; 254(1):204-11. PubMed ID: 1973196 [TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of the adrenoceptor activity of AY-28,925. Rimele TJ; Heaslip RJ; Lee DK; Grimes D J Pharmacol Exp Ther; 1986 Oct; 239(1):1-8. PubMed ID: 2876089 [TBL] [Abstract][Full Text] [Related]
16. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors. Armour JA Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916 [TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo[F]quinoline. Ilhan M; Long JP; Cannon JG J Pharmacol Exp Ther; 1984 Nov; 231(2):361-6. PubMed ID: 6149308 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic. Wong PC; Aldrich PE; Chiu AT; Earl RA; Hart SD; Johnson AL; Ma P; McCall DE; Price WA; Smith RD J Pharmacol Exp Ther; 1993 Jun; 265(3):1088-95. PubMed ID: 8099616 [TBL] [Abstract][Full Text] [Related]
19. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro. Mattsson H; Hedberg A; Carlsson E J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123 [TBL] [Abstract][Full Text] [Related]
20. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens. Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]